COMP <GO>
NOV vs BKR // EV/EBITDA & P/E VALUATION
NOV Inc. (NYSE) VS. Baker Hughes Company (NASDAQ) • 15-METRIC TALLY: NOV 5
— BKR 8
▲ EV/EBITDA & P/E VALUATION LEADER: NOV
LAST: $19.29 (-0.36%) • MKT CAP: $6.90B
valuation
8.7x
LAST: $55.23 (+1.32%) • MKT CAP: $54.13B
valuation
13.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NOV VS. BKR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NOV | BKR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.10% | 11.30% | -5.20 | BKR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 8.7x | 13.6x | -4.90 | NOV | /valuation <GO> |
| Free Cash Flow Yield | 12.69% | 4.73% | +7.96 | NOV | /fcf-yield <GO> |
| Operating Margin | 5.60% | 11.40% | -5.80 | BKR | /operating-margins <GO> |
| Net Profit Margin | 1.70% | 9.30% | -7.60 | BKR | /net-margins <GO> |
| Revenue Growth (YoY) | -1.40% | -0.30% | -1.10 | BKR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.75% | 1.68% | +1.07 | NOV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.03 | 2.62 | -0.59 | BKR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | BKR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.0 | 44.1 | +4.90 | NOV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.09 | +0.02 | NOV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 44.3x | 19.4x | +24.90 | BKR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.90B | $54.13B | -$47.23B | BKR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NOV REV | BKR REV | NOV GROSS % | BKR GROSS % | NOV FCF | BKR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.74B | $27.73B | 20.2% | — | $876.0M | $2.56B |
| FY 2024 | $8.87B | $27.83B | 22.7% | — | $953.0M | $2.08B |
| FY 2023 | $8.58B | $25.51B | — | — | -$243.2M | $1.91B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NOV // BETA 1.11
BKR // BETA 1.09